Robotically assisted surgical device authorized for transvag
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
A novel robotically-assisted surgical device for transvaginal hysterectomy has received marketing authorization approval, the U.S. Food and Drug Administration announced Monday.

The Hominis Surgical System is approved for use in benign hysterectomy with salpingo-oophorectomy, providing a minimally invasive option for noncancerous conditions. The system uses minimally invasive surgical instruments inserted through the vagina and a video camera that is inserted laparoscopically through a small incision in the abdomen.

According to the manufacturer, the surgical robotic platform has miniature humanoid-shaped robotic arms and biomimetic instruments designed to mimic the capabilities and motions of a surgeon's arms.

The approval was based on safety and effectiveness data from 30 patients with varying ages, body mass index, and comorbidities who underwent transvaginal total hysterectomy with salpingo-oophorectomy or salpingectomy for benign conditions. All 30 procedures were successfully completed with the Hominis Surgical System, and none required conversion to an open or other laparoscopic surgery. Reported adverse events included minor blood loss, urinary tract infection, and delayed healing at the vaginal cuff.

Source: https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-robotically-assisted-surgical-device-performing-transvaginal-hysterectomy
Like
Comment
Share
Dr. J●i B●●●●i
Dr. J●i B●●●●i Obstetrics and Gynaecology
Minimally, inv asive technique will prove beneficial for patients who have comorbidities and surgical risk by conventional methods.
Mar 12, 2021Like